Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Most Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded SupplementsCigarette Tax Hike Could Ease Poverty for Millions Worldwide: StudyCDC: Aggressive Action Needed to Contain Antibiotic ResistanceCould Medical Pot Help Curb the Opioid Abuse Crisis?Medical E-Records Not Without Risks: StudyHealth Groups Sue FDA to Speed Review of E-CigarettesEHR Usability Contributes to Possible Patient Harm EventsAHA: Solving the Dilemma of Not Enough HeartsUnchecked Air Pollution a Death Sentence for Millions: StudyPersonal Health Info Found in Recycling at Five HospitalsTask Force Issues Stronger Skin Cancer Prevention GuidelinesFDA Considers Lowering Nicotine Levels in CigarettesDoctors Facing Challenge to Help Needy While Protecting PracticesPharmacists Encouraged to Learn More About Herbal SupplementsBan Menthols to Help Some Smokers QuitStem Cell Clinics Pitch Pricey, Bogus 'Cures' for Knee PainMany Americans Think Docs Order Too Many Tests, MedsIs Herbal Drug Kratom a Health Friend or Foe?Early Studies Often Show Exaggerated Treatment EffectStrong Tobacco Laws May Weed Out Vapers, TooUnderstanding Rx Nonadherence Can Improve AdherenceBystander Use of Defib Device Doubles Chances of Surviving Cardiac ArrestNew Research Debunks Two Medical Marijuana MythsTake Early Clinical Trials With a Grain of SaltCould Hackers Target Heart Devices?Protecting Your Electronic Health RecordsAfter Another Shooting Tragedy, 'Stop the Bleed' Kits Urged for SchoolsPatients Want Physicians to Have Greater ConnectivityYour Tax Dollars Fund Research on Hundreds of New MedsFour Best Practices Outlined to Prevent Health Care CyberattacksMany Patients Know Too Little About Their MRI, CT Scans: StudyUnsafe Water Found in Faucets Across the U.S.Health Tip: Prevent Exposure to LeadHealth Tip: Online Pharmacies You Should AvoidDon't Count on an American to Do CPRPoll: Personal Beliefs Shouldn't Allow Doctors to Refuse to TreatFDA Says U.S. Will Now Produce Critical MRI ComponentPicking a New Primary Care DoctorUber, Lyft Rides May Not Help Boost Doc Visits for Poorer Patients2018 Immunization Schedule Issued for U.S. ChildrenA Hidden Source of 'Superbugs' in Hospitals?2018 Immunization Schedule Issued for U.S. AdultsTop Three Challenges Identified for Pharmacists in 2018Responding to Opioid Crisis, FDA Puts More Restrictions on ImodiumMonkey Deaths Prompt FDA Probe, New Controls on Animal ResearchCDC: Many U.S. Adults Have Never Been Tested for HIVHealth Tip: Performing CPR
Questions and AnswersLinksBook Reviews
Related Topics

Your Tax Dollars Fund Research on Hundreds of New Meds

HealthDay News
by -- Robert Preidt
Updated: Feb 15th 2018

new article illustration

THURSDAY, Feb. 15, 2018 (HealthDay News) -- The U.S. National Institutes of Health spent more than $100 billion on research that led to 210 new medicines gaining U.S. Food and Drug Administration approval over six years, a new study shows.

Nearly $64 billion of that spending was for the development of 84 first-in-class drugs that use new biological mechanisms or targets.

The study is the first to assess how government funding contributes to the development of new medicines, according to the researchers from Bentley University in Waltham, Mass.

"While basic research can sometimes seem esoteric, our analysis shows that a substantial fraction of NIH-funded, basic research can be directly linked to the medicines first approved in this decade," senior study author Dr. Fred Ledley said in a university news release. He's director of the school's Center for Integration of Science and Industry.

"This data underscores the critical impact of government funding for basic biomedical research on the drug discovery and development process," Ledley said. "Any reduction in this funding would inevitably slow the pipeline of new treatments for diseases that the public so desperately needs."

The study team analyzed more than 2 million published research reports directly linked to the 210 new medicines approved by the FDA between 2010 and 2016, or to their biological targets. Of those reports, 600,000 were connected with NIH-funded research projects that involved more than 200,000 fiscal years of research funding and more than $100 billion in total cost, according to the study.

More than 90 percent of that amount was directly associated with research on the biological targets for drug action, rather than the drugs themselves, and represents basic biomedical research, the study authors explained.

The researchers said this type of basic research is "an enabling step leading to the discovery and development of new medicines for untreatable diseases."

The findings were published online Feb. 12 in the Proceedings of the National Academy of Sciences.

More information

The U.S. Food and Drug Administration has more on the drug development process.